Best ways to frame upside / PT for a stock

So this is kind of a newbie question, but curious to hear more thoughts. 

TLDR: Do you ever pitch a thesis where you don't diverge with consensus / don't think its "discounted", but you think the compounding of EPS / ROIC mechanism is > than market growth over next 3yr period, so you buy it anyways? Or in theory, if you are thinking that, that means that you diverge somewhere between what is priced in today?

I will also caveat that I understand that risk/reward is not an explicit price target, and more triangulating across a couple of frameworks to get a sense of ranges, ebbs and flows, etc. 

So super simplistic: ABC makes $10 EPS today, consensus at $12 EPS FY1, I am at $15 EPS. Stock is $100 today. So simple upside is 8.3x $15, or $124.5. Maybe argue that multiple can be different and do ranges here for what a new multiple for this biz is at 50% growth vs. 20% or that expansion in growth rate relative to starting multiple/multiple range needs to be accounted for

You can also do the DCF out by hand if needed, and maybe it says intrinsic price for these characteristics is $124.5 (for whatever that's worth)

Another way I often see is assigning a multiple to another out year estimate and discounting that number back to today by 3-5yrs or whatever

BUT, what if your estimates are mostly in-line with consensus, or not variant to a degree that warrants lots of conviction/other stuff. Yet the business is expected to grow EPS >20% for the next 3yrs. I guess theoretically if the market truly believes that, it should be priced in a way where that growth is hypothetically pulled forward and you don't. 

This gets into the compounder bro world I guess - let business compounding do its magic blah blah, always works best in rear view mirror but credit due to the people who got a few of these right early on 
 

4 Comments
 

When framing upside or price targets (PT) for a stock, especially in scenarios where your estimates align closely with consensus, the approach often shifts to understanding the nuances of growth, valuation, and market expectations. Here's a breakdown based on the most helpful WSO content:

1. Consensus vs. Differentiated View

  • If your estimates are in line with consensus, the key question becomes: Is the market already pricing in the expected growth?
  • High variability scenarios allow for upside even if you agree with consensus, as the range of potential outcomes can still create opportunities. For example, if the variability in value is significant (e.g., $90 to $130), you can still achieve returns even without a differentiated view.
  • However, in low variability scenarios, you must bet against consensus to achieve superior returns. If the market has already priced in the growth, the upside may be limited unless you identify a mispricing or catalyst.

2. Frameworks for Price Target (PT)

  • Simple EPS Multiples:
    • Using your example, if consensus is at $12 EPS FY1 and you're at $15 EPS, you can calculate upside by applying a multiple (e.g., 8.3x) to your estimate. This gives a PT of $124.5.
    • Adjust the multiple based on growth expectations (e.g., 50% growth vs. 20%) or relative to peers.
  • DCF Analysis:
    • A DCF can provide a more intrinsic valuation, but it’s often sensitive to assumptions. It’s useful for triangulating ranges rather than as a standalone PT.
  • Out-Year Multiples Discounted Back:
    • Assign a multiple to an out-year estimate (e.g., FY3 EPS) and discount it back to today using an appropriate rate. This method accounts for compounding growth over time.

3. Compounding Growth Without Divergence

  • If you’re not diverging from consensus but believe in the compounding power of EPS/ROIC, the investment thesis often hinges on:
    • Sustainability of Growth: Is the business positioned to sustain >20% EPS growth for the next 3 years? If so, the market may not fully price in the long-term compounding effect.
    • Catalysts or Mispricing: Even if consensus aligns, there may be underappreciated catalysts (e.g., new product launches, market share gains) that could drive re-rating.
    • Multiple Expansion: If the business demonstrates consistent growth, the market may reward it with a higher multiple over time, creating additional upside.

4. Risk/Reward and Triangulation

  • As you mentioned, risk/reward isn’t an explicit PT but rather a way to frame ranges and scenarios. Consider:
    • Base Case: Aligns with consensus (e.g., $12 EPS, $100 stock price).
    • Bull Case: Your higher estimate ($15 EPS, $124.5 PT).
    • Bear Case: Lower growth or multiple compression.
  • Triangulate across these scenarios to understand the potential ebbs and flows of the stock.

5. "Compounder Bro" Mentality

  • The "let compounding do its magic" approach works best when:
    • The business has a proven track record of compounding EPS/ROIC.
    • The market underestimates the durability of growth or the potential for multiple expansion.
  • While this strategy often looks obvious in hindsight, it requires conviction in the business’s fundamentals and a long-term view.

In summary, even if your estimates align with consensus, you can frame upside by focusing on the sustainability of growth, potential for multiple expansion, and triangulating across scenarios. The key is to identify whether the market has fully priced in the growth or if there’s room for upside through compounding or underappreciated catalysts.

Sources: Understanding Concensus & Differentiated View, Basic Guide Ramping Up On A Company With Public Information Part Three, Stock Pitch Sample Template - Proven Examples to Help Ace Your Interview, A Contrarian View - Raging Bull

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Just stumbled on this while searching for a thread we posted on some time ago (trying to put together a little note on style for my jr's). 

In short, let's break out the actual variance here. If you are $15 EPS vs. street at $12 then you have a $3 variance (+25% to street). Without digging into the actual thesis, the structure of the trade is solid. If you start the frame every trade ideas, whether long or short, near-term or long-term, factor loaded or idio, etc., as essentially a belief in a positive or negative surprise relative to current expectations or estimates, then you're in the right zone. Can always tighten up from there, but that's generally the hurdle to clear. 

 
Most Helpful

Wow digging up a question from my past! 

I think what I was asking, however, is what about where you don't diverge with consensus estimates / mkt estimates a ton. 

I think if you don't diverge, arguably the stock price today = your PT based on all the methods you would assess valuation?

Theoretically, you could just have a situation where business value compounds > other opportunities and > mkt, even if your estimates are in-line with consensus, right? Or perhaps most of the time its just that any excess return opportunity should already be pulled forward and embedded in valuation for something like that.

Like the "compounder" bro era pre 2022/2023 had a lot of investor champions that would argue these types of opportunities. In theory it makes sense that there is a company that could compound value and grow EPS or FCF by 20%/yr for next 10yrs or be a better investment opportunity than mkt/alternatives, AND where the analyst doesn't diverge with consensus that much in their estimates. 

But also, arguably, maybe the mere fact that this value hasn't been pulled forward and discounted by the mkt yet means somewhere in your DCF (years 1-3, years 3-10, 10+ to TV / the multiple) there is some type of divergence or uncertainty discount that you as analyst are staking a claim on. 

ex: cons has $15/$20/$25 as EPS next 3yrs - and mgmt says they can hit $50 in 10yrs, and you also forecast that. I guess in theory, there is likely some debate mkt is grappling with over durability / achievability, of these numbers. Either way, best process to analyze and trade the stock would be to find the revisions/directions/catalyst events that cement the perception of these numbers and their impact on stock price.  

 

Velit natus voluptas eos hic quo unde. Et ducimus cumque fugiat id sequi fugit consequatur. Mollitia cumque minima officia consectetur in error ea. Consequuntur minima aut accusamus aliquam et laudantium. Sed recusandae aut expedita aut. Vero aut repellendus vero ea consequatur et. Voluptas quasi unde quia aut qui nemo. Possimus ducimus qui asperiores praesentium sint est.

Odio aut sunt id voluptas sed beatae ipsam. Sit ducimus delectus at est nam nostrum qui. Et iure laudantium dolorem inventore et. Temporibus labore sapiente aut optio neque.

Et corrupti voluptatem aliquam et necessitatibus doloribus. Veniam eum dolorem consequatur debitis quia.

Eveniet quaerat nesciunt tempore velit. Veritatis optio amet consequuntur asperiores et qui. Fuga eaque explicabo optio ut.

Career Advancement Opportunities

October 2026 Hedge Fund

  • Point72 99.0%
  • D.E. Shaw 98.0%
  • AQR Capital Management 97.0%
  • Citadel Investment Group 96.0%
  • Magnetar Capital 95.0%

Overall Employee Satisfaction

October 2026 Hedge Fund

  • Magnetar Capital 99.0%
  • D.E. Shaw 98.0%
  • Blackstone Group 97.0%
  • Citadel Investment Group 96.0%
  • Two Sigma Investments 94.9%

Professional Growth Opportunities

October 2026 Hedge Fund

  • AQR Capital Management 99.0%
  • Point72 98.0%
  • D.E. Shaw 97.1%
  • Citadel Investment Group 96.1%
  • Magnetar Capital 95.1%

Total Avg Compensation

October 2026 Hedge Fund

  • Portfolio Manager (9) $1,648
  • Vice President (27) $464
  • Director/MD (11) $372
  • NA (9) $320
  • Engineer/Quant (83) $287
  • 3rd+ Year Associate (26) $284
  • Manager (4) $282
  • 2nd Year Associate (32) $253
  • 1st Year Associate (76) $193
  • Analysts (235) $177
  • Intern/Summer Associate (29) $145
  • Junior Trader (5) $102
  • Intern/Summer Analyst (276) $95
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”